Comparative Study of Bispectral Index (BIS) Values Obtained From Standard Frontal Position and Alternative Infra-orbital Position During Total Intravenous Anaesthesia (TIVA).

NCT ID: NCT05441644

Last Updated: 2022-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

71 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-30

Study Completion Date

2022-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to find agreement of the infraorbtal BIS placement as compared to standard frotal placement

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

2.1 Study Design This was a prospective, cross-sectional study conducted in single centre, University Hospital. The study protocol was reviewed and granted approval for implementation by the institution Human Research and Ethics Committee (study protocol code: USM/JEPeM/20060307).

2.2 Study Population We recruited 71 patients who were eligible to be enrolled in this study from November 2020 to October 2021. The inclusion criteria were consented adults between the age of 18 and 60 years old, BMI \> 18 and \<30 kg/m2 and ASA physical status I or II underwent general elective surgery under general anaesthesia. We excluded patients who were going for neurosurgery, maxillofacial or facial surgical procedures because the operation site may interfere with the BIS sensors placement. Patients with a history of disabling central nervous or cerebrovascular disease, those on psychiatric medication or central nervous system active drugs, and those who had undergone neurosurgical procedure were also excluded. The patient who had interruption of BIS monitoring of any BIS sensor location at any time frame will be withdrawn from the study.

The baseline demographic data of patients were extracted from their medical chart. Demographic data include their age, gender, BMI, ASA physical status and type of surgery.

2.3 Study Method Before induction of anaesthesia, we applied two BIS sensors on each patient at different location (frontal \& infra-orbital) and connected two different BIS monitor. Frontal sensors were applied with circle 1 at the centre of forehead, circle 2 2.8cm lateral to circle 1, circle 3 on the corner of the eye and circle 4 in between circle 2 and circle 3 (Picture 1(A)). Infra-orbital sensors were applied with circle 1 across the nose bridge, circle 2 adjacent to circle 1, circle 3 medial from the frontally placed third electrode and circle 4 in between circle 2 and 3 (Picture 1 (B)). Anaesthesia was induced with TCI remifentanil at initial target concentration at 2ng/ml up to 4ng/ml followed with TCI propofol at initial target concentration at 4mcg/ml then titrated upwards to loss of consciousness and intravenous (IV) rocuronium 1.0 mg/kg for muscle relaxant and endotracheal intubation. Anaesthesia was maintained with propofol infusion at target plasma concentration of 3-6mcg/ml and remifentanil 1-8ng/ml; Intra-operative analgesia included IV paracetamol 1g, IV parecoxib 40mg and IV morphine 0.05-0.1mg/kg. At the end of surgery, patients were reversed with IV neostigmine 0.05 mg/kg and atropine 0.02mg/kg. BIS values from each BIS monitor during awake, at loss of consciousness (LOC), after intubation, after the start of surgical incision, every 30 minutes during the intraoperative period (maintenance), after cessation of TCI propofol at which the plasma concentration of propofol is 1.5mcg/ml (emergence) and at extubation were recorded. The frontal BIS was used to guide the depth of anaesthesia, with deep (BIS \< 45), moderate (BIS 45 to 60) and mild hypnosis (BIS \>60).

2.4 Sample Size In order to determine the Kappa agreement for Pearson's correlation between BIS values obtained from frontal versus the infra-orbital sensor position, using t-test, the sample size would be determined with parameter of effect 0.3, an alpha of 0.05 and a power of 80%. The sample size required was 64 patients and with the estimation of 10% drop-out rate, the total number would be 71 patients.

In order to determine the relationship between BIS values obtained from frontal versus the infra-orbital sensor position, using linear regression, the sample size would be determined with parameter of effect size 0.15, an alpha of 0.05 and a power of 80%. The sample size required was 55 patients.

To satisfy both outcomes, the final sample size for this study would be 71 patients.

2.5 Statistical Analysis Data were recorded and analyzed using SPSS for Window version 22.0. Descriptive statistics were used to summarize the socio-demographic characteristics of subjects. Numerical data were presented as mean (SD) or median (IQR) based on their normality distribution. Categorical data were presented as number and percentage. Correlation of the numerical data obtained from the two different groups were analyzed using Pearson's correlation and scatter plot analysis. Relationship between data obtained from the two groups was determined using simple linear regression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intraoperative Awareness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

two way mixed effect model; aggreement study
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

frontal BIS

frontal BIS is a standard position

Group Type PLACEBO_COMPARATOR

Bispectral index

Intervention Type DEVICE

A new placemewnt to monitor intraoperative BIS

infraorbital BIS

Infraorbital BIS is a comparator to find agreement with standard location

Group Type ACTIVE_COMPARATOR

Bispectral index

Intervention Type DEVICE

A new placemewnt to monitor intraoperative BIS

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bispectral index

A new placemewnt to monitor intraoperative BIS

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

The inclusion criteria were consented adults between the age of 18 and 60 years old, BMI \> 18 and \<30 kg/m2 and ASA physical status I or II underwent general elective surgery under general anaesthesia.

Exclusion Criteria

We excluded patients who were going for neurosurgery, maxillofacial or facial surgical procedures because the operation site may interfere with the BIS sensors placement. Patients with a history of disabling central nervous or cerebrovascular disease, those on psychiatric medication or central nervous system active drugs, and those who had undergone neurosurgical procedure were also excluded. The patient who had interruption of BIS monitoring of any BIS sensor location at any time frame will be withdrawn from the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universiti Sains Malaysia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamad Hasyizan Hassan

Senior Lecturer and Neuroanaesthesiologist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

School Of Medical Sciences, Health Campus, Universioti Sains Malaysia

Kubang Kerian, Kelantan, Malaysia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malaysia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

USM/JEPeM/20060307

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.